Financials
- Market Capitalization 403.53 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
3.68
市销率
35.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3044 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 3.73 USD | +0.27% | 0.00% | +19.17% | +16.20% | 409.46 M USD | ||
| 3046 | LRMR Larimar Therapeutics, Inc. - Common Stock | 3.94 USD | +3.14% | -4.83% | +2.87% | +6.20% | 409.30 M USD | ||
| 3064 | EYPT EyePoint, Inc. - Common Stock | 4.58 USD | +1.78% | -8.76% | -62.88% | -61.83% | 394.85 M USD | ||
| 3068 | ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.51 USD | +1.35% | -3.50% | +6.38% | +49.12% | 393.48 M USD |